Samsung Biologics Reports Fourth Quarter & Fiscal Year 2023 Financial Results

Recorded Q4’23 consolidated revenue of KRW 1.07 trillion and Q4’23 operating profit of KRW 350 billion Recorded FY’23 consolidated revenue of KRW 3.69 trillion and FY’23 operating profit of KRW 1.1 trillion Exceeded KRW 1 trillion consolidated operating income for the first time,…